Anti-PD-1 blockade led to the mice harboring many more T cells expressing PD-1, LAG-3, and TIGIT compared to the non-treatment mice After anti-PD-1 anti-TIGIT blockade, there was evidence of reduced tumor growth, increased overall survival, and more expression of CD8+ T cells. Here, PDCD1 is linked to neoplasm.